1. Home
  2. HWBK vs IRWD Comparison

HWBK vs IRWD Comparison

Compare HWBK & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HWBK

Hawthorn Bancshares Inc.

HOLD

Current Price

$34.46

Market Cap

231.4M

Sector

Finance

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.23

Market Cap

251.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWBK
IRWD
Founded
1865
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
231.4M
251.8M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
HWBK
IRWD
Price
$34.46
$3.23
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$5.34
AVG Volume (30 Days)
11.3K
2.5M
Earning Date
01-21-2026
11-10-2025
Dividend Yield
2.19%
N/A
EPS Growth
259.86
N/A
EPS
3.19
0.18
Revenue
$77,904,000.00
$338,987,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.01
P/E Ratio
$11.43
$17.67
Revenue Growth
45.83
N/A
52 Week Low
$25.21
$0.53
52 Week High
$36.49
$5.13

Technical Indicators

Market Signals
Indicator
HWBK
IRWD
Relative Strength Index (RSI) 54.12 50.16
Support Level $33.85 $3.50
Resistance Level $36.25 $3.84
Average True Range (ATR) 0.99 0.27
MACD -0.01 -0.11
Stochastic Oscillator 29.80 19.48

Price Performance

Historical Comparison
HWBK
IRWD

About HWBK Hawthorn Bancshares Inc.

Hawthorn Bancshares Inc is a financial holding company and along with its subsidiary, it conducts general banking and trust business, offering its customers checking and savings accounts, internet banking, certificates of deposit, trust services, brokerage services, and safety deposit boxes. The company also offers a range of lending services, including commercial and industrial loans, single payment personal loans, installment loans, and commercial and residential real estate loans.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: